GB2401044B - A composition for use in the treatment or prophylaxis of a skin condition in a subject - Google Patents

A composition for use in the treatment or prophylaxis of a skin condition in a subject

Info

Publication number
GB2401044B
GB2401044B GB0409694A GB0409694A GB2401044B GB 2401044 B GB2401044 B GB 2401044B GB 0409694 A GB0409694 A GB 0409694A GB 0409694 A GB0409694 A GB 0409694A GB 2401044 B GB2401044 B GB 2401044B
Authority
GB
United Kingdom
Prior art keywords
prophylaxis
subject
treatment
composition
skin condition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
GB0409694A
Other versions
GB0409694D0 (en
GB2401044A (en
Inventor
Julie Elizabeth Almond
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of GB0409694D0 publication Critical patent/GB0409694D0/en
Publication of GB2401044A publication Critical patent/GB2401044A/en
Application granted granted Critical
Publication of GB2401044B publication Critical patent/GB2401044B/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A61K9/0017—Non-human animal skin, e.g. pour-on, spot-on
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/01—Hydrocarbons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/02—Medicinal preparations containing materials or reaction products thereof with undetermined constitution from inanimate materials
    • A61K35/04—Tars; Bitumens; Mineral oils; Ammonium bituminosulfonate
    • A61K35/06—Mineral oils, e.g. paraffinic oils or aromatic oils based on aromatic hydrocarbons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/886—Aloeaceae (Aloe family), e.g. aloe vera
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/46—Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
GB0409694A 2003-05-02 2004-04-30 A composition for use in the treatment or prophylaxis of a skin condition in a subject Expired - Lifetime GB2401044B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0310147.4A GB0310147D0 (en) 2003-05-02 2003-05-02 A composition for use in the treatment of a skin condition in a subject

Publications (3)

Publication Number Publication Date
GB0409694D0 GB0409694D0 (en) 2004-06-02
GB2401044A GB2401044A (en) 2004-11-03
GB2401044B true GB2401044B (en) 2007-03-07

Family

ID=9957398

Family Applications (2)

Application Number Title Priority Date Filing Date
GBGB0310147.4A Ceased GB0310147D0 (en) 2003-05-02 2003-05-02 A composition for use in the treatment of a skin condition in a subject
GB0409694A Expired - Lifetime GB2401044B (en) 2003-05-02 2004-04-30 A composition for use in the treatment or prophylaxis of a skin condition in a subject

Family Applications Before (1)

Application Number Title Priority Date Filing Date
GBGB0310147.4A Ceased GB0310147D0 (en) 2003-05-02 2003-05-02 A composition for use in the treatment of a skin condition in a subject

Country Status (1)

Country Link
GB (2) GB0310147D0 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2409159B (en) * 2003-12-15 2008-02-20 Donald Henry Yates A preparation for use in the treatment of mud fever in horses
DK2271342T3 (en) * 2008-03-28 2012-10-29 Elanco Animal Health Ireland Use of nicotinamide for the treatment of summer eczema in horses
EP2106794A1 (en) * 2008-04-04 2009-10-07 Eden Horse B.V. Ubiquitin alone or in combination for use in the treatment of sweet itch.

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1927916A (en) * 1930-05-15 1933-09-26 Standard Oil Dev Co Emulsified alcohol product and method of making the same
EP0156565A2 (en) * 1984-03-07 1985-10-02 Yamanouchi Pharmaceutical Co. Ltd. Antipruritic compositions and plasters
US4816254A (en) * 1987-07-29 1989-03-28 Moss Thomas D Ointment for treating skin irritations
US5023251A (en) * 1985-09-28 1991-06-11 Beiersdorf Ag O/W cream containing hydrocortisone diester
GB2337461A (en) * 1998-05-22 1999-11-24 Hewlett Healthcare Limited Formulations for topicval administration
US6348501B1 (en) * 1999-09-29 2002-02-19 Medical Merchandising, Inc. Lotion compositions utilizing capsaicin
RU2207124C1 (en) * 2002-04-24 2003-06-27 Закрытое акционерное общество "Брынцалов-А" Cream "bramizil" with antifungal effect

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1927916A (en) * 1930-05-15 1933-09-26 Standard Oil Dev Co Emulsified alcohol product and method of making the same
EP0156565A2 (en) * 1984-03-07 1985-10-02 Yamanouchi Pharmaceutical Co. Ltd. Antipruritic compositions and plasters
US5023251A (en) * 1985-09-28 1991-06-11 Beiersdorf Ag O/W cream containing hydrocortisone diester
US4816254A (en) * 1987-07-29 1989-03-28 Moss Thomas D Ointment for treating skin irritations
GB2337461A (en) * 1998-05-22 1999-11-24 Hewlett Healthcare Limited Formulations for topicval administration
US6348501B1 (en) * 1999-09-29 2002-02-19 Medical Merchandising, Inc. Lotion compositions utilizing capsaicin
RU2207124C1 (en) * 2002-04-24 2003-06-27 Закрытое акционерное общество "Брынцалов-А" Cream "bramizil" with antifungal effect

Also Published As

Publication number Publication date
GB0310147D0 (en) 2003-06-04
GB0409694D0 (en) 2004-06-02
GB2401044A (en) 2004-11-03

Similar Documents

Publication Publication Date Title
HRP20130602T1 (en) 2,4-pyrimidinediamine compounds for use in the treatment or prevention of autoimmune diseases
TWI348381B (en) Skin cleansing composition
GB0520687D0 (en) Skin treatment formulations
HK1089376A1 (en) Formulation for use in the prevention and treatment of carbohydrate induced ; diseases and conditions
HK1082916A1 (en) Composition for preparation for external use on skin
HK1095739A1 (en) Skin care composition
AU2003223694A8 (en) Durable hair treatment composition
EP1543034A4 (en) Treatment and prophylaxis with 4-1bb-binding agents
PL1732575T3 (en) Strontium-containing compounds for use in the prevention or treatment of necrotic bone conditions
IL180929A0 (en) The use of n-aryl diazaspiracyclic compounds in the treatment of addiction
ZA200410409B (en) Use of thio-oxindole derivatives in treatment of hormonerelated conditions
IL178827A0 (en) Use of reboxetine for the treatment of pain
EP1933853A4 (en) Tissue disruption treatment and composition for use thereof
GB2411834B (en) Composition for use in the treatment of dry skin conditions
GB0415181D0 (en) Compounds for use in the treatment of infection
HUP0300990D0 (en) Synergistic combination for the prophylaxis and treatment of diabetes
SG110107A1 (en) Compound and use in treatment
GB2401044B (en) A composition for use in the treatment or prophylaxis of a skin condition in a subject
GB2431349B (en) A composition for treating the skin of human feet
GB0425633D0 (en) Topical formulations for use in the treatment or prevention of dermatological conditions
GB0427637D0 (en) Topical formulations for use in the treatment or prevention of skin cancers
GB2392839A8 (en) Use of Mycobacterium w in the treatment of tubercolosis
IL162492A0 (en) Use of alkylphosphocholines for the preventative treatment of protozoandiseases
GB0505203D0 (en) Skin composition treatment
EP1660007A4 (en) Compositions for diabetes treatment and prophylaxis